Analysis of Erectile Responses to BAY 41-8543 and Muscarinic Receptor Stimulation in the Rat

Journal of Sexual Medicine

Volumn 10, Issue 3, 2013, Pages 704-718

  Lasker, George F ^a   Pankey, Edward A ^a   Allain, Alexander V ^a   Dhaliwal, Jasdeep S ^a   Stasch, Johannes Peter ^b   Murthy, Subramanyam N ^a   Kadowitz, Philip J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYER AG   (Germany)

Author keywords

BAY 41 8543; Cavernosal Nerve Stimulation; Erectile Function; Increased cGMP; Muscarinic Receptors; SGC Stimulator

Indexed keywords

2 [1 (2 FLUOROBENZYL) 1H PYRAZOLO[3,4 B]PYRIDIN 3 YL] 5 MORPHOLINO 4,6 PYRIMIDINEDIAMINE; ATROPINE; GUANYLATE CYCLASE; MUSCARINIC RECEPTOR; NITROPRUSSIDE SODIUM; SOLUBLE GUANYLATE CYCLASE; UNCLASSIFIED DRUG;

ARTICLE; CAVERNOSAL NERVE INJURY; INTRACAVERNOSAL PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NERVE INJURY; NERVE STIMULATION; NONHUMAN; PENIS ERECTION; PRESSURE AND TENSION; PRIORITY JOURNAL; RAT;

EID: 84874673007     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02912.x     Document Type: Article

References (32)

1. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP. NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential. Nat Rev Drug Discov 2006;5:755-68.
2. Mizusawa H, Hedlund P, Brioni JD, Sullivan JP, Andersson KE. Nitric oxide independent activation of guanylate cyclase by YC-1 causes erectile responses in the rat. J Urol 2002;167:2276-81.
3. Stasch JP, Hobbs AJ. NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb Exp Pharmacol 2009;131:277-308.
4. Bischoff E, Schramm M, Straub A, Feurer A, Stasch JP. BAY 41-2272: A stimulator of soluble guanylyl cyclase induces nitric oxide-dependent penile erection in vivo. Urology 2003;61:464-7.
5. Stasch JP, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Minuth T, Perzborn E, Schramm M, Straub A. Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: In vitro studies. Br J Pharmacol 2002;135:333-43.
6. Saenz de Tejada I, Angulo J, Cellek S, González-Cadavid N, Heaton J, Pickard R, Simonsen U. Physiology of erectile function. J Sex Med 2004;1:254-65.
7. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-32.
8. Bivalacqua TJ, Champion HC, Abdel-Mageed AB, Kadowitz PJ, Hellstrom WJ. Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod 2001;65:1371-7.
9. Bivalacqua TJ, Champion HC, Purohit SK, Murphy WA, Coy DH, Kadowitz PJ, Hellstrom WJ. Nitric oxide-mediated erectile effects of galantide but not galanin in vivo. Nitric Oxide 2000;4:94-102.
10. Champion HC, Bivalacqua TJ, Hyman AL, Ignarro LJ, Hellstrom WJ, Kadowitz PJ. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A 1999;96:11648-52.
11. Rask-Madsen C, King GL. Mechanisms of disease: Endothelial dysfunction in insulin resistance and diabetes. Nat Clin Pract Endocrinol Metab 2007;3:46-56.
12. de Tejada IS. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat. Int J Impot Res 2004;16(suppl 1):S40-2.
13. Padma-Nathan H, McCullough A, Forest C. Erectile dysfunction secondary to nerve-sparing radical retropubic prostatectomy: Comparative phosphodiesterase-5 inhibitor efficacy for therapy and novel prevention strategies. Curr Urol Rep 2004;5:467-71.
14. Angulo J, Gonzalez-Corrochano R, Cuevas P, Fernández A, La Fuente JM, Rolo F, Allona A, Sáenz de Tejada I. Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries. J Sex Med 2010;7:758-68.
15. Shimokawa H. Primary endothelial dysfunction: Atherosclerosis. J Mol Cell Cardiol 1999;31:23-37.
16. Thomas GD, Zhang W, Victor RG. Nitric oxide deficiency as a cause of clinical hypertension: Promising new drug targets for refractory hypertension. JAMA 2001;285:2055-7.
17. Nakane M, Hsieh G, Miller LN, Chang R, Terranova MA, Moreland RB, Kolasa T, Brioni JD. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: Synergism of nitric oxide and YC-1. Int J Impot Res 2002;14:121-7.
18. Hsieh GC, O'Neill AB, Moreland RB, Sullivan JP, Brioni JD. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats. Eur J Pharmacol 2003;458:183-9.
19. Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P, Maggi M. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. J Sex Med 2010;7:59-69.
20. Hedlund P, Alm P, Andersson KE. NO synthase in cholinergic nerves and NO-induced relaxation in the rat isolated corpus cavernosum. Br J Pharmacol 1999;127:349-60.
21. Spiess PE, Dion SB, Zvara P, Merlin SL, Chan PT, Brock GB. 7-Nitroindazole: A selective inhibitor of penile erection: An in vivo study in a rat animal model. Urology 1996;47:93-6.
22. Mas M, Escrig A, Gonzalez-Mora JL. In vivo electrochemical measurement of nitric oxide in corpus cavernosum penis. J Neurosci Methods 2002;119:143-50.
23. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995;75:191-236.
24. Stief C, Benard F, Bosch R, Aboseif S, Nunes L, Lue TF, Tanagho EA. Acetylcholine as a possible neurotransmitter in penile erection. J Urol 1989;141:1444-8.
25. Stief C, Diederichs W, Benard F, Bosch R, Aboseif S, Lue TF, Tanagho EA. Possible role for acetylcholine as a neurotransmitter in canine penile erection. Urol Int 1989;44:357-63.
26. Suh JK, Mun KH, Cho CK, Shin HC, Kim YS, Park TC. Effect of vasoactive intestinal peptide and acetylcholine on penile erection in the rat in vivo. Int J Impot Res 1995;7:111-8.
27. Senbel AM, Hashad A, Sharabi FM, Daabees TT. Activation of muscarinic receptors inhibits neurogenic nitric oxide in the corpus cavernosum. Pharmacol Res 2012;65:303-11.
28. Trigo-Rocha F, Hsu GL, Donatucci CF, Lue TF. The role of cyclic adenosine monophosphate, cyclic guanosine monophosphate, endothelium and nonadrenergic, noncholinergic neurotransmission in canine penile erection. J Urol 1993;149:872-7.
29. Senbel AM, Hasha A, Sharabi FM, Daabees TT. Activation of muscarinic receptors inhibits neurogenic nitric oxide in the corpus cavernosum. Pharmacol Res 2012;65:303-11.
30. Carati CJ, Creed KE, Keogh EJ. Autonomic control of penile erection in the dog. J Physiol 1987;384:525-38.
31. Dail WG, Walton G, Olmsted MP. Penile erection in the rat: Stimulation of the hypogastric nerve elicits increases in penile pressure after chronic interruption of the sacral parasympathetic outflow. J Auton Nerv Syst 1989;28:251-7.
32. Larsson B, Andersson KE, Mattiasson A. Influence of antimuscarinics on alpha-adrenoceptors in the female rabbit urethra. Acta Physiol Scand 1984;120:537-42.